The Research Council of Norway and The Norwegian Cancer Society has funded a new Centre for Clinical Treatment Research called – MATRIX; Multimodal Approach Targeting treatment Refractory Cancers usIng neXt generation technology

The overall objective of a Centre for Clinical Treatment Research is to establish clinical research groups that help to improve treatments for Norwegian patients by way of outstanding research.

In MATRIX, the overall aim is to help cancer patients to live longer and better. This will be achieved through better classification of the patients (i.e. improved and extensive diagnostic assessment) enabling tailored interventions and new treatment alternatives tested through clinical trials. The centre will primarily focus on cancer patients with poor prognosis, plans to include >1000 patients in clinical trials. MATRIX will develop new systems for patient-involvement in treatment decisions to develop optimal patient-centred cancer care.

“We are very happy to receive this funding. It gives us a great opportunity to conduct more clinical studies. We will develop new methods for asking the patients about symptoms and their physical, psychological and social life. We will develop digital patient care pathways and obtain the patient’s voice”, says professor Stein Kaasa head of PRC and the department of oncology at Oslo University hospital. In MATRIX there are 5 WPs, including one work package on patient-centred care.